Cancer Society Drops Alcohol Industry Fundraiser

The American Cancer Society just made a choice that puts science over money.

The organization quietly canceled its Wine and Spirits Industry Gala, an annual Manhattan fundraiser that had brought in at least $22 million from alcohol executives over the years. The October event at New York's Rainbow Room won't be happening.

"The decision is part of ACS's ongoing evaluation of how its events and fundraising activities align with its mission and prevention guidance," spokesperson Michele Money-Carson told STAT News.

The gala had created an uncomfortable situation for decades. A charity dedicated to fighting cancer was hosting boozy parties funded by an industry whose product is linked to causing cancer. Research has shown clear connections between alcohol consumption and several types of cancer, including breast, liver, and colon cancer.

The tension became harder to ignore after STAT News highlighted the issue in its "Deadliest Drug" series this summer. Even a former American Cancer Society executive called the arrangement inappropriate and said it created a conflict of interest.

Why This Inspires

This decision matters because it shows a major health organization choosing integrity over easy money. Twenty-two million dollars is significant funding for any nonprofit. Walking away from that kind of revenue stream takes courage.

The American Cancer Society isn't saying alcohol is evil or that people who enjoy wine are doing something wrong. They're simply acknowledging that their fundraising approach should match their health guidance. If they're telling people that alcohol increases cancer risk, hosting parties funded by liquor companies sends a confusing message.

Other health organizations are watching. When a charity as large and influential as the American Cancer Society makes this kind of change, it sets a new standard. It sends a message that credibility and mission alignment matter more than keeping donors comfortable.

The cancellation also reflects growing public awareness about alcohol's health risks. People are asking tougher questions about corporate influence in health spaces. They want the organizations they trust to be consistent in word and deed.

For cancer patients and survivors who support the American Cancer Society, this move validates their trust. The organization heard concerns and acted on them, even when it meant making a financially difficult choice.

The decision proves that even long-standing traditions can change when they no longer serve an organization's core purpose.